Hey everyone! I grabbed a triple espresso here at the café, and let's break down what's really moving the market today, July 23, 2026.
Let's get straight to the point: I've picked the 4-6 news items that will most impact your portfolio in the coming months. Forget the noise, focus on what matters.
---
###
1. China Dominates Shipyards: New Orders Surge 173%
Fact: The Chinese shipbuilding industry (CSSC, for example) posted an all-time record for new orders in the first half of 2026, up 173% year-over-year, gobbling up over 62% of the global market.
Effect: I Would Buy the *shipbuilding* and maritime logistics sectors. The order boom guarantees years of revenue.
Affected Assets/Sectors: CSSC (China State Shipbuilding Corp), Vale S.A. (VALE3 - iron ore needs ships), maritime shipping (Drewry Shipping Index), steel and heavy plates (Gerdau - GOAU4).
###
2. AMD Signs Billion-Dollar Deal with Anthropic (Challenging Nvidia)
Fact: AMD (AMD) signed a multi-hundred-billion-dollar contract with Anthropic to supply AI chips starting in 2027, equivalent to 2 gigawatts of processing power.
Effect: I Would Buy AMD. This deal pulls AMD out of Nvidia's (NVDA) shadow and positions it as a key player in AI infrastructure.
Affected Assets/Sectors: AMD (AMD), Nvidia (NVDA), semiconductor suppliers (ASML), data centers, and server electricity.
###
3. Neuralink Valued at $42 Billion: Hype or New Frontier?
Fact: Investors are valuing Neuralink, Elon Musk's brain-chip startup, at an impressive $42 billion, even before significant revenue.
Effect: I Would Hold (or watch from afar). The valuation is too aggressive for a company with no revenue. It's a bet, not an investment. I wouldn't buy, but I'd keep an eye on the neurotechnology sector.
Affected Assets/Sectors: Tesla (TSLA - Musk correlation), biotech and medical implant companies, AI and precision medical hardware sectors.
###
4. DEXE Tokens Collapse 80%, Ondo Soars 15%: July Crypto Madness
Fact: The DeXe (DEXE) token suffered an exploit and lost 80% of its value in 24 hours, while the Ondo token (ONDO) surged 14.8% with explosive volume.
Effect: I Would Sell (or avoid) DEXE.
I Would Buy (small position) ONDO, due to volume and resistance breakout.
Affected Assets/Sectors: Bitcoin (BTC - sector sentiment), Ethereum (ETH - contract base), DeXe (DEXE), Ondo Finance (ONDO).
###
5. China Approves Innovative Therapy Before US: Global Health Shift
Fact: China approved a globally innovative drug for the first time before the US, Japan, and Europe, signaling leadership in biotechnology.
Effect: I Would Buy Chinese biotech companies and Asia-focused healthcare ETFs. This move accelerates drug approvals in the Asian giant.
Affected Assets/Sectors: WuXi AppTec (603259.SH), iShares MSCI China Health Care ETF, pharmaceutical companies operating in China, research labs.
---
###
Immediate Opportunities
-
Ships & Logistics: Buy shares of Chinese shipbuilders (CSSC) and maritime shipping companies. Commodity demand is set to explode.
-
AMD (AMD): The Anthropic deal is a game-changer. Get in now before the market prices it in.
-
Ondo Finance (ONDO): If you have the stomach for crypto, the resistance breakout with high volume is a bullish signal.
-
Chinese Biotech: China-focused healthcare ETFs are cheap. Accelerated drug approvals will turbocharge the sector.
###
Risks on the Radar
-
Crypto Exploit (DEXE): The DEXE collapse shows the token market is full of pitfalls. Stay away from projects with little auditing.
-
AI Overvaluation (Neuralink): Early-stage companies with $42 billion valuations can create a bubble. Beware the herd mentality.
-
Commodity Dependence: The Chinese shipbuilding boom depends on steel and iron ore prices. Any Chinese slowdown could flip the script.
---
Source Links:
Shipbuilding China record |
AMD + Anthropic deal |
Neuralink $42B valuation |
DEXE collapse |
ONDO rally |
China drug approval breakthrough
---
*This analysis is personal opinion and does not constitute investment advice.*